USD/IDR to near the 15,000 level in the coming months – DBS Bank USDIDR Indonesia Fed Banks
compared to 13,575-16,625 last year. In 2022, economists at DBS Bank expect USD/IDR to trade around the 14,500-15,000 region.“IDR to depreciate into 14,500-15,000 per USD ahead of two Fed hikes in 4Q22.”
“The central bank intends to keep rates low for most of next year to help the nascent recovery gain traction. In line with BI’s guidance, we have pencilled in a rate hike to 3.75% from 3.50% in 4Q22.” growth to pick up to 4.8% in 2022 from a projected 3.6% in 2021, and CPI inflation double to 3.0% from 1.5%.”Information on these pages contains forward-looking statements that involve risks and uncertainties.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
15 Celeb Weddings That Were Super Low-Key And 15 Celeb Weddings That Were Wildly ExtravagantOh, to have millions to spend on a wedding...
続きを読む »
Pediatrician answers your questions on Pfizer Covid-19 booster for ages 12-15The FDA gave emergency use authorization for booster doses of Pfizer/BioNTech's Covid-19 vaccine for children ages 12 to 15 on Monday. A pediatrician answers parents' questions about the shots.
続きを読む »
FDA authorizes Pfizer COVID-19 boosters for 12- to 15-year oldsThe FDA on Monday authorized Pfizer COVID-19 boosters for 12- to 15-year olds amid the omicron surge as children head back to school.
続きを読む »
FDA Backs Pfizer Booster for 12- to 15-Year-OldsThe agency also took two related actions in the revised emergency use authorization for the Pfizer/BioNTech vaccine.
続きを読む »